{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:11:00Z","timestamp":1791407460406,"version":"4.3.3"},"reference-count":194,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006541","name":"Comunidad de Madrid Consejer\u00eda de Sanidad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.pharmthera.2021.107933","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T09:17:33Z","timestamp":1624526253000},"page":"107933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Pathophysiological and pharmacological relevance of TLR4 in peripheral immune cells after stroke"],"prefix":"10.1016","volume":"228","author":[{"given":"V.","family":"Dur\u00e1n-Laforet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pe\u00f1a-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Garc\u00eda-Culebras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Alzamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Lizasoain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2021.107933_bb0005","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3934\/Allergy.2018.3.126","article-title":"Basophil activation through TLR2 and TLR4 signaling pathways","volume":"2","author":"Alkan","year":"2018","journal-title":"AIMS Allergy Immunol."},{"key":"10.1016\/j.pharmthera.2021.107933_bb0010","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1182\/blood-2005-03-0916","article-title":"Platelets express functional Toll-like receptor-4","volume":"106","author":"Andonegui","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0015","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1001\/jama.2011.1853","article-title":"The search for effective therapy for sepsis: Back to the drawing board? JAMA - J","volume":"306","author":"Angus","year":"2011","journal-title":"Am. Med. Assoc."},{"key":"10.1016\/j.pharmthera.2021.107933_bb0020","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1126\/science.1142883","article-title":"Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior","volume":"317","author":"Auffray","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0025","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1146\/annurev.immunol.021908.132557","article-title":"Blood monocytes: Development, heterogeneity, and relationship with dendritic cells","volume":"27","author":"Auffray","year":"2009","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0030","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1126\/science.1085536","article-title":"Toll-like receptor signaling pathways","volume":"300","author":"Barton","year":"2003","journal-title":"Science."},{"key":"10.1016\/j.pharmthera.2021.107933_bb0035","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1161\/01.STR.32.1.206","article-title":"Antibody to the \u03b14 integrin decreases infarct size in transient focal cerebral ischemia in rats","volume":"32","author":"Becker","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0040","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/sj.jcbfm.9600160","article-title":"Sensitization to brain antigens after stroke is augmented by lipopolysaccharide","volume":"25","author":"Becker","year":"2005","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0045","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.4049\/jimmunol.168.7.3536","article-title":"The Proinflammatory CD14 + CD16 + DR ++ Monocytes Are a Major Source of TNF","volume":"168","author":"Belge","year":"2002","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0050","doi-asserted-by":"crossref","DOI":"10.1007\/s12975-021-00887-4","article-title":"Immune Cell Infiltration into the Brain After Ischemic Stroke in Humans Compared to Mice and Rats: a Systematic Review and Meta-Analysis","author":"Beuker","year":"2021","journal-title":"Translational Stroke Research"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0055","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.immuni.2010.11.011","article-title":"Neutrophils, from marrow to microbes","volume":"33","author":"Borregaard","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0060","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.pharmtox.010909.105547","article-title":"Discovery and development of therapeutic aptamers","volume":"50","author":"Bouchard","year":"2010","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0065","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.4049\/jimmunol.1601948","article-title":"Activation of Myeloid TLR4 Mediates T Lymphocyte Polarization after Traumatic Brain Injury","volume":"198","author":"Braun","year":"2017","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0070","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1111\/jcmm.12304","article-title":"Regulatory T cells modulate inflammation and reduce infarct volume in experimental brain ischaemia","volume":"18","author":"Brea","year":"2014","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0075","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/jcbfm.2010.231","article-title":"Toll-like receptors 2 and 4 in ischemic stroke: Outcome and therapeutic values","volume":"31","author":"Brea","year":"2011","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0080","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/STROKEAHA.107.490128","article-title":"Early neutrophilia is associated with volume of ischemic tissue in acute stroke","volume":"39","author":"Buck","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0085","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12975-019-00694-y","article-title":"Functional dynamics of neutrophils after ischemic stroke","volume":"11","author":"Cai","year":"2019","journal-title":"Translational Stroke Research"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-019-0118-8","article-title":"Ischaemic stroke","volume":"5","author":"Campbell","year":"2019","journal-title":"Nature Reviews. Disease Primers"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0095","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.bbrc.2006.12.057","article-title":"Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice","volume":"353","author":"Cao","year":"2007","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0100","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/CIRCULATIONAHA.106.603431","article-title":"Toll-Like Receptor 4 Is Involved in Brain Damage and Inflammation After Experimental Stroke","volume":"115","author":"Caso","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037584","article-title":"TLR2, TLR4 and the MYD88 Signaling Pathway Are Crucial for Neutrophil Migration in Acute Kidney Injury Induced by Sepsis","volume":"7","author":"Castoldi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0110","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neuint.2017.06.008","article-title":"Chemokines play complex roles in cerebral ischemia","volume":"112","author":"Chen","year":"2018","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0115","first-page":"148","article-title":"State-of-the-art review about basophil research in immunology and allergy: Is the time right to treat these cells with the respect they deserve?","volume":"10","author":"Chirumbolo","year":"2012","journal-title":"Blood Transfusion"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0120","doi-asserted-by":"crossref","first-page":"16327","DOI":"10.1523\/JNEUROSCI.3611-11.2011","article-title":"CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents","volume":"31","author":"Cipriani","year":"2011","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0125","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.coph.2012.06.002","article-title":"New developments in Toll-like receptor targeted therapeutics","volume":"12","author":"Connolly","year":"2012","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0130","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1161\/STROKEAHA.113.002470","article-title":"N2 neutrophils, novel players in brain inflammation after stroke: modulation by the PPAR\u03b3 agonist rosiglitazone","volume":"44","author":"Cuartero","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cellimm.2006.08.006","article-title":"Lactoferrin activates macrophages via TLR4-dependent and -independent signaling pathways","volume":"242","author":"Curran","year":"2006","journal-title":"Cellular Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0140","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/STROKEAHA.115.011238","article-title":"Thromboinflammation in stroke brain damage","volume":"47","author":"De Meyer","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0145","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/ATVBAHA.110.208918","article-title":"Binding of von Willebrand factor to collagen and glycoprotein Ib\u03b1, but not to glycoprotein IIb\/IIIa, contributes to ischemic stroke in mice-brief report","volume":"30","author":"De Meyer","year":"2010","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0150","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/sj.jcbfm.9600495","article-title":"Proliferating resident microglia after focal cerebral ischaemia in mice","volume":"27","author":"Denes","year":"2007","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0155","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-5793(03)00482-4","article-title":"Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4","volume":"544","author":"Devaney","year":"2003","journal-title":"FEBS Letters"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0160","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/01.STR.0000259709.16654.8f","article-title":"Absence of the Chemokine Receptor CCR2 Protects Against Cerebral Ischemia\/Reperfusion Injury in Mice","volume":"38","author":"Dimitrijevic","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0165","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1523\/JNEUROSCI.4098-14.2015","article-title":"B-lymphocyte-mediated delayed cognitive impairment following stroke","volume":"35","author":"Doyle","year":"2015","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0170","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","article-title":"Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials","volume":"384","author":"Emberson","year":"2014","journal-title":"Lancet."},{"key":"10.1016\/j.pharmthera.2021.107933_bb0175","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1515\/revneuro-2013-0069","article-title":"The role of Toll-like receptors (TLRs) in stroke","volume":"25","author":"Fadakar","year":"2014","journal-title":"Reviews in the Neurosciences"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0180","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nm832","article-title":"Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptors","volume":"9","author":"Fan","year":"2003","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0185","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1161\/CIRCRESAHA.116.308413","article-title":"Global burden of stroke","volume":"120","author":"Feigin","year":"2017","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0190","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.ymthe.2018.05.019","article-title":"TLR4-Binding DNA aptamers show a protective effect against acute stroke in animal models","volume":"26","author":"Fern\u00e1ndez","year":"2018","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0195","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1189\/jlb.0306170","article-title":"S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules","volume":"81","author":"Foell","year":"2007","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0200","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1084\/jem.191.8.1413","article-title":"P-selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo","volume":"191","author":"Frenette","year":"2000","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0205","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \"N1\" versus \"N2\" TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0210","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/01616412.1993.11740130","article-title":"Pharmacological effects of ibudilast on cerebral circulation: A PET study","volume":"15","author":"Fukuyama","year":"1993","journal-title":"Neurological Research"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0215","first-page":"121","article-title":"The role of inflammation and interleukin-1 in acute cerebrovascular disease","volume":"6","author":"Galea","year":"2013","journal-title":"Journal of Inflammation Research"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0220","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1073\/pnas.1315943111","article-title":"Ischemic neurons recruit natural killer cells that accelerate brain infarction","volume":"111","author":"Gan","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2014.00044","article-title":"Immune mechanisms in cerebral ischemic tolerance","volume":"8","author":"Garcia-Bonilla","year":"2014","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0230","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12974-016-0750-0","article-title":"Spatio-temporal profile, phenotypic diversity, and fate of recruited monocytes into the post-ischemic brain","volume":"13","author":"Garcia-Bonilla","year":"2016","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0235","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1161\/STROKEAHA.119.025085","article-title":"Role of TLR4 (Toll-Like Receptor 4) in N1\/N2 Neutrophil Programming After Stroke","volume":"50","author":"Garc\u00eda-Culebras","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0240","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1074-7613(03)00174-2","article-title":"Blood monocytes consist of two principal subsets with distinct migratory properties","volume":"19","author":"Geissmann","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0245","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/STROKEAHA.108.534503","article-title":"Temporal and spatial dynamics of cerebral immune cell accumulation in stroke","volume":"40","author":"Gelderblom","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0250","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav2309","article-title":"Novel reprogramming of neutrophils modulates inflammation resolution during atherosclerosis","volume":"5","author":"Geng","year":"2019","journal-title":"Science Advances"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0255","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/CIRCRESAHA.119.315380","article-title":"Circulating monocyte chemoattractant protein-1 and risk of stroke meta-analysis of population-based studies involving 17180 individuals","volume":"125","author":"Georgakis","year":"2019","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0260","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.coph.2015.09.009","article-title":"Dynamics of T cell responses after stroke","volume":"26","author":"Gill","year":"2016","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0265","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev.iy.02.040184.002241","article-title":"Immunobiology of Eosinophils","volume":"2","author":"Gleich","year":"1984","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0270","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0167-5699(00)01735-7","article-title":"NKT cells: Facts, functions and fallacies","volume":"21","author":"Godfrey","year":"2000","journal-title":"Immunology Today"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0275","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","article-title":"DAMP-sensing receptors in sterile inflammation and inflammatory diseases","volume":"20","author":"Gong","year":"2019","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0280","series-title":"Journal of the American College of Surgeons","first-page":"38","article-title":"LPS-induced decrease of neutrophil apoptosis is regulated through TLR2, not through TLR4","author":"Goshima","year":"2004"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0285","first-page":"3643","article-title":"The role of eosinophils in stroke: a pilot study","volume":"19","author":"Guo","year":"2015","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0290","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000111499","article-title":"Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans","volume":"25","author":"Haeusler","year":"2008","journal-title":"Cerebrovascular Diseases"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0295","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0006-3495(92)81577-1","article-title":"Simulation of cell rolling and adhesion on surfaces in shear flow: general results and analysis of selectin-mediated neutrophil adhesion","volume":"63","author":"Hammer","year":"1992","journal-title":"Biophysical Journal"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0300","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1523\/JNEUROSCI.4070-13.2014","article-title":"CCR2+Ly6Chi inflammatory monocyte recruitment exacerbates acute disability following intracerebral hemorrhage","volume":"34","author":"Hammond","year":"2014","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0305","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1007\/s10072-020-04777-9","article-title":"The role of peripheral monocytes and macrophages in ischemic stroke","volume":"41","author":"Han","year":"2020","journal-title":"Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0310","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/ATVBAHA.112.300679","article-title":"Angiogenesis mediated by toll-like receptor 4 in ischemic neural tissue","volume":"33","author":"He","year":"2013","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0320","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10555-017-9677-x","article-title":"Normal platelet function","volume":"36","author":"Holinstat","year":"2017","journal-title":"Cancer Metastasis Reviews"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0325","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.4049\/jimmunol.168.9.4531","article-title":"Quantitative Expression of Toll-Like Receptor 1\u201310 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides","volume":"168","author":"Hornung","year":"2002","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb7000","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jneuroim.2007.08.014","article-title":"Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia\/reperfusion","volume":"190","author":"Hua","year":"2007","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0330","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/jcbfm.2014.240","article-title":"TAK-242, an antagonist for Toll-like receptor 4, protects against acute cerebral ischemia\/reperfusion injury in mice","volume":"35","author":"Hua","year":"2015","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0335","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00004647-200203000-00008","article-title":"Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model","volume":"22","author":"Hughes","year":"2002","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0340","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/sj.jcbfm.9600482","article-title":"T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation","volume":"27","author":"Hurn","year":"2007","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0345","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1039\/c9tx00048h","article-title":"Inhibitions of HMGB1 and TLR4 alleviate DINP-induced asthma in mice","volume":"8","author":"Hwang","year":"2019","journal-title":"Toxicol. Res. (Camb)."},{"key":"10.1016\/j.pharmthera.2021.107933_bb0350","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.neuroscience.2010.08.054","article-title":"Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia","volume":"171","author":"Hyakkoku","year":"2010","journal-title":"Neuroscience."},{"key":"10.1016\/j.pharmthera.2021.107933_bb0355","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nm.2399","article-title":"The immunology of stroke: From mechanisms to translation","volume":"17","author":"Iadecola","year":"2011","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0360","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/01.WCB.0000132690.96836.7F","article-title":"Platelet-leukocyte-endothelial cell interactions after middle cerebral artery occlusion and reperfusion","volume":"24","author":"Ishikawa","year":"2004","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0365","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3389\/fimmu.2019.00686","article-title":"Autoimmunity after ischemic stroke and brain injury","volume":"10","author":"Javidi","year":"2019","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0370","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12974-019-1516-2","article-title":"Neuroinflammation: friend and foe for ischemic stroke","volume":"10","author":"Jayaraj","year":"2019","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0375","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.18632\/oncotarget.12201","article-title":"Changes in the cellular immune system and circulating inflammatory markers of stroke patients","volume":"8","author":"Jiang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0380","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fimmu.2013.00011","article-title":"Lipopolysaccharide induces IFN-\u03b3 production in human NK cells","volume":"4","author":"Kanevskiy","year":"2013","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0385","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nm1589","article-title":"Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists","volume":"13","author":"Kanzler","year":"2007","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0390","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/01.WCB.0000117812.35136.5B","article-title":"Leukocyte-endothelium interactions during permanent focal cerebral ischemia in mice","volume":"24","author":"Kataoka","year":"2004","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0395","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: Update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nature Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0400","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5607\/en.2016.25.5.241","article-title":"Inflammation after Ischemic Stroke: The Role of Leukocytes and Glial Cells","volume":"25","author":"Kim","year":"2016","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.pharmthera.2021.107933_bb0405","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/cells10010015","article-title":"Monocyte Recruitment, Specification, and Function in Atherosclerosis","volume":"10","author":"Kim","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0410","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1182\/blood-2012-04-426734","article-title":"Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature","volume":"121","author":"Kleinschnitz","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0415","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/CIRCULATIONAHA.107.691279","article-title":"Targeting platelets in acute experimental stroke: Impact of glycoprotein Ib, VI, and IIb\/IIIa blockade on infarct size, functional outcome, and intracranial bleeding","volume":"115","author":"Kleinschnitz","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20060043","article-title":"(Peri)vascular production and action of pro-inflammatory cytokines in brain pathology","volume":"112","author":"Konsman","year":"2007","journal-title":"Clinical Science"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0425","first-page":"22","article-title":"Leukocytosis in patients with neurologic deterioration after acute ischemic stroke is associated with poor outcomes","author":"Kumar","year":"2013","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"key":"10.1016\/j.pharmthera.2021.107933_bb5000","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00401-018-1930-z","article-title":"Post-stroke inflammation-target or tool for therapy?","volume":"137","author":"Lambersten","year":"2019","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0430","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1053\/trre.2003.2","volume":"17","author":"Land","year":"2003","journal-title":"Transplantation Reviews"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0435","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.STR.31.6.1223","article-title":"Medical complications after stroke: a multicenter study","volume":"31","author":"Langhorne","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0440","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ana.24993","article-title":"Neutrophil extracellular traps in ischemic stroke thrombi","volume":"82","author":"Laridan","year":"2017","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0445","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cellimm.2006.08.004","article-title":"The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity","volume":"241","author":"Lauzon","year":"2006","journal-title":"Cellular Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0450","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.brainres.2011.11.007","article-title":"Ibudilast, a phosphodiesterase inhibitor with anti-inflammatory activity, protects against ischemic brain injury in rats","volume":"1431","author":"Lee","year":"2012","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0455","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0304-3940(00)00907-1","article-title":"Quantitative changes in interleukin proteins following focal stroke in the rat","volume":"282","author":"Legos","year":"2000","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2021.107933_bb6000","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jneuroim.2007.07.023","article-title":"Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia","volume":"190","author":"Lehnardt","year":"2007","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0465","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neulet.2014.07.003","article-title":"Intracerebral interleukin-10 injection modulates post-ischemic neuroinflammation: an experimental microarray study","volume":"579","author":"Liesz","year":"2014","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0470","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nm.1927","article-title":"Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke","volume":"15","author":"Liesz","year":"2009","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0475","doi-asserted-by":"crossref","first-page":"17350","DOI":"10.1523\/JNEUROSCI.4901-12.2013","article-title":"Boosting regulatory T cells limits Neuroinflammation in permanent cortical stroke","volume":"33","author":"Liesz","year":"2013","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0480","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1152\/physrev.00012.2018","article-title":"The Neutrophil\u2019s role during health and disease","volume":"99","author":"Liew","year":"2019","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0485","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1161\/STROKEAHA.115.012079","article-title":"Interleukin-4 Is Essential for Microglia\/Macrophage M2 Polarization and Long-Term Recovery After Cerebral Ischemia","volume":"47","author":"Liu","year":"2016","journal-title":"Stroke."},{"key":"10.1016\/j.pharmthera.2021.107933_bb0490","doi-asserted-by":"crossref","first-page":"7341","DOI":"10.1002\/jcp.27493","article-title":"CXCL8 gene silencing promotes neuroglial cells activation while inhibiting neuroinflammation through the PI3K\/Akt\/NF-\u03baB-signaling pathway in mice with ischemic stroke","volume":"234","author":"Lv","year":"2019","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0495","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/cvr\/cvw024","article-title":"Temporal neutrophil polarization following myocardial infarction","volume":"110","author":"Ma","year":"2016","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0500","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","article-title":"Tolerance, Danger, and the Extended Family","volume":"12","author":"Matzinger","year":"1994","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0505","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of Mice and Not Men: Differences between Mouse and Human Immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0510","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/jcbfm.2014.80","article-title":"The impact of Ly6C low monocytes after cerebral hypoxia-ischemia in adult mice","volume":"34","author":"Michaud","year":"2014","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0515","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbi.2015.08.010","article-title":"Immature monocytes recruited to the ischemic mouse brain differentiate into macrophages with features of alternative activation","volume":"53","author":"Mir\u00f3-Mur","year":"2016","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0520","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/35097097","article-title":"A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells","volume":"413","author":"Miyamoto","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0525","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.neuropharm.2003.09.009","article-title":"Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia","volume":"46","author":"Mizuno","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0530","article-title":"Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: A phase II study","volume":"79","author":"Monnet","year":"2019","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0535","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/01.CIR.0000152105.79665.C6","article-title":"Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: A pilot investigation","volume":"111","author":"Moore","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0540","doi-asserted-by":"crossref","first-page":"109","DOI":"10.7326\/0003-4819-102-1-109","article-title":"Neurologic dysfunction in the idiopathic hypereosinophilic syndrome","volume":"102","author":"Moore","year":"1985","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0545","doi-asserted-by":"crossref","DOI":"10.1038\/srep13886","article-title":"Non-Classical monocytes display inflammatory features: Validation in Sepsis and Systemic Lupus Erythematous","volume":"5","author":"Mukherjee","year":"2015","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0550","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1600-0897.2009.00717.x","article-title":"Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4\/MyD88 pathway","volume":"62","author":"Mulla","year":"2009","journal-title":"American Journal of Reproductive Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0555","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3389\/fimmu.2014.00313","article-title":"Toll-like receptor 4 in inflammation and angiogenesis: a double-edged sword","volume":"5","author":"Murad","year":"2014","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0560","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.4049\/jimmunol.171.8.3977","article-title":"Expression and Function of Toll-Like Receptors in Eosinophils: Activation by Toll-Like Receptor 7 Ligand","volume":"171","author":"Nagase","year":"2003","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0565","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","article-title":"Global, regional, and national age-sex specifc mortality for 264 causes of death, 1980-2016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"Naghavi","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0570","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrd3203","article-title":"Targeting Toll-like receptors: Emerging therapeutics?","volume":"9","author":"O\u2019Neill","year":"2010","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0575","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.STR.16.2.224","article-title":"Platelet accumulation in regions of low blood flow during the postischemic period","volume":"16","author":"Obrenovitch","year":"1985","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0580","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jneuroim.2012.04.005","article-title":"Alteration of immunologic responses on peripheral blood in the acute phase of ischemic stroke: Blood genomic profiling study","volume":"249","author":"Oh","year":"2012","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0585","doi-asserted-by":"crossref","first-page":"558","DOI":"10.4049\/jimmunol.164.2.558","article-title":"Cutting Edge: Heat Shock Protein 60 Is a Putative Endogenous Ligand of the Toll-Like Receptor-4 Complex","volume":"164","author":"Ohashi","year":"2000","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0590","doi-asserted-by":"crossref","first-page":"10229","DOI":"10.1074\/jbc.M100099200","article-title":"The Extra Domain A of Fibronectin Activates Toll-like Receptor 4","volume":"276","author":"Okamura","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0595","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bbi.2019.05.002","article-title":"Toll-like receptor 4 regulates subventricular zone proliferation and neuroblast migration after experimental stroke","volume":"80","author":"Palma-Tortosa","year":"2019","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0600","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1111\/bph.14703","article-title":"Early toll-like receptor 4 blockade reduces ROS and inflammation triggered by microglial pro-inflammatory phenotype in rodent and human brain ischaemia models","volume":"176","author":"Parada","year":"2019","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0605","doi-asserted-by":"crossref","first-page":"C917","DOI":"10.1152\/ajpcell.00401.2005","article-title":"High mobility group box 1 protein interacts with multiple Toll-like receptors","volume":"290","author":"Park","year":"2006","journal-title":"American Journal of Physiology. Cell Physiology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0610","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1177\/0271678X20909055","article-title":"CCR2 deficiency in monocytes impairs angiogenesis and functional recovery after ischemic stroke in mice","volume":"40","author":"Pedragosa","year":"2020","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0615","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1161\/STROKEAHA.119.026848","article-title":"Pharmacological Modulation of Neutrophil Extracellular Traps Reverses Thrombotic Stroke tPA (Tissue-Type Plasminogen Activator) Resistance","volume":"50","author":"Pe\u00f1a-Mart\u00ednez","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0620","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1471-4159.2009.05972.x","article-title":"Toll-like receptor 4 is involved in neuroprotection afforded by ischemic preconditioning","volume":"109","author":"Pradillo","year":"2009","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0625","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.coph.2011.06.007","article-title":"The role of TLRs in neutrophil activation","volume":"11","author":"Prince","year":"2011","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0630","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7915","article-title":"Extracellular MRP8\/14 is a regulator of \u03b222 integrin-dependent neutrophil slow rolling and adhesion","volume":"6","author":"Pruenster","year":"2015","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0635","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0165-2478(02)00210-9","article-title":"Toll-like receptor-4 is involved in eliciting an LPS-induced oxidative burst in neutrophils","volume":"85","author":"Remer","year":"2003","journal-title":"Immunology Letters"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0640","doi-asserted-by":"crossref","first-page":"8556","DOI":"10.1523\/JNEUROSCI.1623-11.2011","article-title":"Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke","volume":"31","author":"Ren","year":"2011","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0645","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11011-010-9226-6","article-title":"CD4+FoxP3+ regulatory T-cells in cerebral ischemic stroke","volume":"26","author":"Ren","year":"2011","journal-title":"Metabolic Brain Disease"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0650","first-page":"761","article-title":"Regulatory Effects of Toll-like Receptor 4 Knockout on CD4+ and CD8+ T Lymphocytes and Interleukin-17 During Myocardial Ischemia","volume":"50","author":"Ren","year":"2020","journal-title":"Annals of Clinical and Laboratory Science"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0655","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0049-3848(01)00258-4","article-title":"Potentiation of ibudilast inhibition of platelet aggregation in the presence of endothelial cells","volume":"102","author":"Rile","year":"2001","journal-title":"Thrombosis Research"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0660","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1161\/01.STR.31.5.1153","article-title":"Leukocyte accumulation and hemodynamic changes in the cerebral microcirculation during early reperfusion after stroke","volume":"31","author":"Ritter","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0665","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-015-0329-1","article-title":"Functional differences between microglia and monocytes after ischemic stroke","volume":"12","author":"Ritzel","year":"2015","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0670","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1615\/CritRevImmunol.v31.i5.20","article-title":"LPS-induced cytokine production in human monocytes and macrophages","volume":"31","author":"Rossol","year":"2011","journal-title":"Critical Reviews in Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0675","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5140679","article-title":"Thrombosis, Neuroinflammation, and Poststroke Infection: The Multifaceted Role of Neutrophils in Stroke","author":"Ruhnau","year":"2017","journal-title":"Journal of Immunology Research"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0680","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.4049\/jimmunol.168.9.4701","article-title":"Toll-Like Receptor (TLR)2 and TLR4 in Human Peripheral Blood Granulocytes: A Critical Role for Monocytes in Leukocyte Lipopolysaccharide Responses","volume":"168","author":"Sabroe","year":"2002","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0685","series-title":"Biochemical Society Transactions, (Biochem Soc Trans)","first-page":"468","article-title":"What can we learn from highly purified neutrophils?","author":"Sabroe","year":"2004"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0690","doi-asserted-by":"crossref","first-page":"5268","DOI":"10.4049\/jimmunol.170.10.5268","article-title":"Selective Roles for Toll-Like Receptor (TLR)2 and TLR4 in the Regulation of Neutrophil Activation and Life Span","volume":"170","author":"Sabroe","year":"2003","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0695","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","article-title":"An updated definition of stroke for the 21st century: A statement for healthcare professionals from the American heart association\/American stroke association","volume":"44","author":"Sacco","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0700","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/icb.2010.130","article-title":"Toward a functional characterization of blood monocytes","volume":"89","author":"Saha","year":"2011","journal-title":"Immunology and Cell Biology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0705","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.4103\/1673-5374.165208","article-title":"Neuroinflammation and comorbidities are frequently ignored factors in CNS pathology","volume":"10","author":"Sandu","year":"2015","journal-title":"Neural Regeneration Research"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0710","first-page":"305","article-title":"Multiple microembolic borderzone brain infarctions and endomyocardial fibrosis in idiopathic hypereosinophilic syndrome and in Schistosoma mansoni infestation","volume":"75","author":"Sarazin","year":"2004","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0715","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/JLB.MR0618-213R","article-title":"Platelet TLR4 at the crossroads of thrombosis and the innate immune response","volume":"105","author":"Schattner","year":"2019","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0720","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0301-472X(01)00733-0","article-title":"Of mice and men: Comparison of the ultrastructure of megakaryocytes and platelets","volume":"29","author":"Schmitt","year":"2001","journal-title":"Experimental Hematology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0725","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12974-017-0890-x","article-title":"B cells do not have a major pathophysiologic role in acute ischemic stroke in mice","volume":"14","author":"Schuhmann","year":"2017","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0730","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev.immunol.26.021607.090326","article-title":"Monocyte-mediated defense against microbial pathogens","volume":"26","author":"Serbina","year":"2008","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0735","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1232221","article-title":"Tumor-associated neutrophils display a distinct N1 profile following TGF\u03b2 modulation: A transcriptomics analysis of pro- vs. antitumor TANs","volume":"5","author":"Shaul","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0740","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.4049\/jimmunol.167.5.2887","article-title":"Fibrinogen Stimulates Macrophage Chemokine Secretion Through Toll-Like Receptor 4","volume":"167","author":"Smiley","year":"2001","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0745","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCRESAHA.111.257535","article-title":"Multiple roles for neutrophils in atherosclerosis","volume":"110","author":"Soehnlein","year":"2012","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0750","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/01.STR.30.1.134","article-title":"Mice deficient in Mac-1 (CD11b\/CD18) are less susceptible to cerebral ischemia\/reperfusion injury","volume":"30","author":"Soriano","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0755","doi-asserted-by":"crossref","first-page":"391","DOI":"10.6061\/clinics\/2013(03)OA17","article-title":"Blockade of CXCR1\/2 chemokine receptors protects against brain damage in ischemic stroke in mice","volume":"68","author":"Sousa","year":"2013","journal-title":"Clinics (S\u00e3o Paulo, Brazil)"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0760","doi-asserted-by":"crossref","first-page":"R206","DOI":"10.1186\/cc11838","article-title":"Toll-like receptors expression and interferon-\u03b3 production by NK cells in human sepsis","volume":"16","author":"Souza-Fonseca-Guimaraes","year":"2012","journal-title":"Critical Care"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0765","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MOT.0000000000000041","article-title":"Innate immune cells in transplantation","volume":"19","author":"Spahn","year":"2014","journal-title":"Current Opinion in Organ Transplantation"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0770","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1126\/science.1256478","article-title":"Neutrophils scan for activated platelets to initiate inflammation","volume":"346","author":"Sreeramkumar","year":"2014","journal-title":"Science (80-. )"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0775","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041254","article-title":"Platelet-derived toll-like receptor 4 (Tlr-4) is sufficient to promote microvascular thrombosis in endotoxemia","volume":"7","author":"Stark","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0780","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/jcbfm.2012.128","article-title":"Regulatory T cells accumulate and proliferate in the ischemic hemisphere for up to 30 days after MCAO","volume":"33","author":"Stubbe","year":"2013","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0785","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1084\/jem.20100479","article-title":"Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection","volume":"208","author":"Sun","year":"2011","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0790","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/intimm\/dxy041","article-title":"The role of immune cells in brain development and neurodevelopmental diseases","volume":"30","author":"Tanabe","year":"2018","journal-title":"International Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0795","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.expneurol.2008.05.014","article-title":"Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal","volume":"213","author":"Tang","year":"2008","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0800","doi-asserted-by":"crossref","first-page":"13798","DOI":"10.1073\/pnas.0702553104","article-title":"Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits","volume":"104","author":"Tang","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0805","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.jcbfm.9600264","article-title":"Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: A microarray study","volume":"26","author":"Tang","year":"2006","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0810","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.20001858","article-title":"Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4","volume":"195","author":"Termeer","year":"2002","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0815","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2249.2008.03650.x","article-title":"T helper 1 (Th1)\/Th2 cytokine expression shift of peripheral blood CD4 + and CD8+ T cells in patients at the post-acute phase of stroke","volume":"152","author":"Theodorou","year":"2008","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0820","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.2337\/db20-0568","article-title":"A high glycemic burden relates to functional and metabolic alterations of human monocytes in patients with type 1 diabetes","volume":"69","author":"Thiem","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0825","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/ATVBAHA.114.304650","article-title":"Nonclassical Patrolling Monocyte Function in the Vasculature","volume":"35","author":"Thomas","year":"2015","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0830","first-page":"1151","article-title":"Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke","volume":"314","author":"Trialists","year":"1997","journal-title":"Stroke Unit Trialists\u2019 Collaboration. BMJ"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0835","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.immuni.2004.07.006","article-title":"Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus","volume":"21","author":"Tsuda","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0840","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/STROKEAHA.108.532085","article-title":"Monocytes are major players in the prognosis and risk of infection after acute stroke","volume":"40","author":"Urra","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0845","series-title":"Monocytes Are Major Players in the Prognosis and Risk of Infection After Acute Stroke","author":"Urra","year":"2009"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0850","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/jcbfm.2009.25","article-title":"Monocyte subtypes predict clinical course and prognosis in human stroke","volume":"29","author":"Urra","year":"2009","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0855","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fimmu.2014.00316","article-title":"A comparative review of toll-like receptor 4 expression and functionality in different animal species","volume":"5","author":"Vaure","year":"2014","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0860","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nature Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0865","doi-asserted-by":"crossref","first-page":"104238","DOI":"10.18632\/oncotarget.22199","article-title":"The significance of eosinophils in predicting the severity of acute ischemic stroke","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0870","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/STROKEAHA.113.001038","article-title":"Toll-like receptor 4 antagonist attenuates intracerebral hemorrhage-induced brain injury","volume":"44","author":"Wang","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0875","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1523\/JNEUROSCI.4317-15.2016","article-title":"Monocyte-derived macrophages contribute to spontaneous long-term functional recovery after stroke in mice","volume":"36","author":"Wattananit","year":"2016","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0880","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-8-87","article-title":"A role for tumor necrosis factor-\u03b1 in ischemia and ischemic preconditioning","volume":"8","author":"Watters","year":"2011","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0885","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2017.00108","article-title":"Clinical applications of the eosinophilic esophagitis diagnostic panel","volume":"4","author":"Wen","year":"2017","journal-title":"Frontiers in Medicine"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0890","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/imr.12548","article-title":"Recent advances in understanding basophil-mediated Th2 immune responses","volume":"278","author":"Yamanishi","year":"2017","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0895","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/jcbfm.2008.50","article-title":"Upregulated expression of toll-like receptor 4 in monocytes correlates with severity of acute cerebral infarction","volume":"28","author":"Yang","year":"2008","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0900","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/jcbfm.2010.129","article-title":"HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling","volume":"31","author":"Yang","year":"2011","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0905","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1161\/STROKEAHA.110.608257","article-title":"Blood-brain barrier breakdown in acute and chronic cerebrovascular disease","volume":"42","author":"Yang","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0910","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1124\/pr.117.014530","article-title":"Platelet signaling and disease: Targeted therapy for thrombosis and other related diseases","volume":"70","author":"Yeung","year":"2018","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0915","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-25741-w","article-title":"Effects of the Th2-dominant milieu on allergic responses in der f 1-activated mouse basophils and mast cells","volume":"8","author":"Yi","year":"2018","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0920","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s12017-009-8074-1","article-title":"Leukocyte recruitment and ischemic brain injury","volume":"12","author":"Yilmaz","year":"2010","journal-title":"Neuromolecular Medicine"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0925","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nature15367","article-title":"Neutrophil ageing is regulated by the microbiome","volume":"525","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0930","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/brb3.1382","article-title":"Neutrophil-to-lymphocyte ratio predicts hemorrhagic transformation in ischemic stroke: A meta-analysis","volume":"9","author":"Zhang","year":"2019","journal-title":"Brain and Behavior: A Cognitive Neuroscience Perspective"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0935","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-11-79","article-title":"Accumulation of natural killer cells in ischemic brain tissues and the chemotactic effect of IP-10","volume":"11","author":"Zhang","year":"2014","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0940","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1365-2567.2007.02573.x","article-title":"In vivo kinetics of human natural killer cells: The effects of ageing and acute and chronic viral infection","volume":"121","author":"Zhang","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0945","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/FJC.0000000000000876","article-title":"The Role of Immune Cells in Cardiac Remodeling After Myocardial Infarction","volume":"76","author":"Zhang","year":"2020","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0950","doi-asserted-by":"crossref","first-page":"5244","DOI":"10.4049\/jimmunol.0901309","article-title":"Role of Endothelial TLR4 for Neutrophil Recruitment into Central Nervous System Microvessels in Systemic Inflammation","volume":"183","author":"Zhou","year":"2009","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0955","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1523\/JNEUROSCI.22-10-03898.2002","article-title":"Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage","volume":"22","author":"Zhu","year":"2002","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0960","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.bbrc.2007.05.157","article-title":"TLR2 has a detrimental role in mouse transient focal cerebral ischemia","volume":"359","author":"Ziegler","year":"2007","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2021.107933_bb0965","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2010-02-258558","article-title":"Nomenclature of monocytes and dendritic cells in blood","volume":"116","author":"Ziegler-Heitbrock","year":"2010","journal-title":"Blood"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725821001352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725821001352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:17:53Z","timestamp":1759011473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725821001352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":194,"alternative-id":["S0163725821001352"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107933","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiological and pharmacological relevance of TLR4 in peripheral immune cells after stroke","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107933","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107933"}}